Skip to content

Effect of Cutting Blades for Total Knee Arthroplasty on Implant Migration

Effect of Cutting Blades for Total Knee Arthroplasty on Implant Migration. A Randomized Controlled Study With Radiostereometric Analysis

Status
Withdrawn
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01772589
Enrollment
0
Registered
2013-01-21
Start date
2015-02-28
Completion date
2015-02-28
Last updated
2018-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteoarthritis

Brief summary

There have been considerable efforts to control rising health care costs. One of the more recent developments is the practice of reprocessing single use medical devices. This practice has been shown to provide considerable savings for health care payers. Medical devices have been reprocessed in a number of different medical fields including Orthopaedic Surgery. One of the devices that has been reprocessed are the Precision Saw Blades from Stryker Inc. These saw blades are used during Total Knee Arthroplasty (TKA) surgery. The reprocessed Precision saw blades are Health Canada approved and are available at Capital Health. Beyond the benefits to the environment and cost savings, the investigators do not know if the reprocessed saw blades work better, work worse or the same as non reprocessed saw blades. This study is designed to determine if the reprocessed saw blades used during a TKA work as well as a new saw blade.

Interventions

PROCEDURENew saw blade
PROCEDUREReprocessed saw blade

Sponsors

Glen Richardson
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
21 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Symptomatic osteoarthritis of the knee indicating surgical intervention 2. Between the ages of 21 and 80 inclusive 3. Ability to give informed consent

Exclusion criteria

1. Significant co-morbidity affecting ability to ambulate 2. Flexion contracture greater than 15° 3. Extension lag greater than 10° 4. Tibial subluxation greater than 10 mm on standing AP radiograph 5. Prior arthroplasty, patellectomy or osteotomy with the affected knee 6. Lateral or medial collateral ligament instability (\> 10° varus/valgus) 7. Leg length discrepancy greater than 10 mm 8. Bone quality precluding uncemented fixation 9. Pregnancy 10. Active or prior infection 11. Morbid Obesity (BMI \> 40) 12. Medical condition precluding major surgery 13. Severe osteoporosis or osteopenia 14. Neuromuscular impairment

Design outcomes

Primary

MeasureTime frameDescription
Implant migration2 yearsImplant migration assessed with RSA

Secondary

MeasureTime frameDescription
Economics1 yearCost comparison of saw blades

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026